U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 97

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr1:201009500
GRCh38:
Chr1:201040372
CACNA1SC1743*Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1Pathogenic
(Oct 21, 2021)
criteria provided, single submitter
2.
GRCh37:
Chr1:201009504
GRCh38:
Chr1:201040376
CACNA1SMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1Likely pathogenic
(Oct 1, 2019)
criteria provided, single submitter
3.
GRCh37:
Chr1:201009753
GRCh38:
Chr1:201040625
CACNA1SC1741*Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Pathogenic
(Dec 21, 2021)
criteria provided, single submitter
4.
GRCh37:
Chr1:201012490
GRCh38:
Chr1:201043362
CACNA1SL1656fsHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Pathogenic
(Dec 24, 2021)
criteria provided, single submitter
5.
GRCh37:
Chr1:201012510
GRCh38:
Chr1:201043382
CACNA1SD1650fsMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1Pathogenic
(Feb 28, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr1:201012526
GRCh38:
Chr1:201043398
CACNA1SL1644*Hypokalemic periodic paralysisLikely pathogenic
(Nov 22, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr1:201012583-201012586
GRCh38:
Chr1:201043455-201043458
CACNA1SN1624fsHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Pathogenic
(Dec 17, 2019)
criteria provided, single submitter
8.
GRCh37:
Chr1:201012623
GRCh38:
Chr1:201043495
CACNA1SL1612fsHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Pathogenic
(Oct 30, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr1:201012638
GRCh38:
Chr1:201043510
CACNA1SQ1607*Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1Pathogenic
(Jan 1, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr1:201012661
GRCh38:
Chr1:201043533
CACNA1SMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, not provided,
Hypokalemic periodic paralysis, type 1
Likely pathogenic
(Jun 21, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr1:201013554-201013584
GRCh38:
Chr1:201044426-201044456
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Pathogenic
(Jun 18, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr1:201016651
GRCh38:
Chr1:201047523
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, not provided
Likely pathogenic
(Aug 19, 2020)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr1:201016756
GRCh38:
Chr1:201047628
CACNA1SMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1Likely pathogenic
(Dec 30, 2021)
criteria provided, single submitter
14.
GRCh37:
Chr1:201019548
GRCh38:
Chr1:201050420
CACNA1SA1404fsHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Pathogenic
(Aug 2, 2021)
criteria provided, single submitter
15.
GRCh37:
Chr1:201019585
GRCh38:
Chr1:201050457
CACNA1SW1391*Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Pathogenic
(May 13, 2021)
criteria provided, single submitter
16.
GRCh37:
Chr1:201019586
GRCh38:
Chr1:201050458
CACNA1SW1391*Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1Pathogenic
(Apr 9, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr1:201020111
GRCh38:
Chr1:201050983
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
Likely pathogenic
(Sep 15, 2022)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr1:201020111
GRCh38:
Chr1:201050983
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
Likely pathogenic
(Jul 6, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr1:201020187
GRCh38:
Chr1:201051059
CACNA1SE1348fsnot providedLikely pathogenic
(Jun 19, 2019)
criteria provided, single submitter
20.
GRCh37:
Chr1:201020200
GRCh38:
Chr1:201051072
CACNA1SS1342*Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Pathogenic
(Oct 31, 2018)
criteria provided, single submitter
21.
GRCh37:
Chr1:201020237
GRCh38:
Chr1:201051109
CACNA1SL1330fsHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Pathogenic
(May 17, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr1:201021683
GRCh38:
Chr1:201052555
CACNA1SMalignant hyperthermia, susceptibility to, 5Likely pathogenic
(Jun 24, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr1:201022587
GRCh38:
Chr1:201053459
CACNA1SQ1265Hnot provided, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5,
Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Likely pathogenic
(Oct 20, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr1:201022609
GRCh38:
Chr1:201053481
CACNA1SW1258*Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Pathogenic
(Aug 13, 2021)
criteria provided, single submitter
25.
GRCh37:
Chr1:201022622
GRCh38:
Chr1:201053494
CACNA1SR1254*Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1Pathogenic
(Mar 20, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr1:201022656
GRCh38:
Chr1:201053528
CACNA1SR1242SHypokalemic periodic paralysis, type 1Likely pathogenic
(Apr 12, 2022)
no assertion criteria provided
27.
GRCh37:
Chr1:201022657
GRCh38:
Chr1:201053529
CACNA1SR1242KHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Pathogenic
(Jun 27, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr1:201022658
GRCh38:
Chr1:201053530
CACNA1SR1242GAbnormality of the musculaturePathogenic
(Jul 10, 2021)
criteria provided, single submitter
29.
GRCh37:
Chr1:201022666
GRCh38:
Chr1:201053538
CACNA1SR1239HHypokalemic periodic paralysis, type 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5,
not provided
Pathogenic
(Oct 25, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr1:201022667
GRCh38:
Chr1:201053539
CACNA1SR1239CHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Likely pathogenic
(Jul 27, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr1:201022667
GRCh38:
Chr1:201053539
CACNA1SR1239Gnot provided, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Pathogenic
(Oct 4, 2021)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr1:201022716
GRCh38:
Chr1:201053588
CACNA1SHypokalemic periodic paralysis, type 1Likely pathogenic
(Nov 18, 2020)
criteria provided, single submitter
33.
GRCh37:
Chr1:201027621
GRCh38:
Chr1:201058493
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
Pathogenic/Likely pathogenic
(Jun 20, 2022)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr1:201028316
GRCh38:
Chr1:201059188
CACNA1SMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1Likely pathogenic
(Jun 18, 2021)
criteria provided, single submitter
35.
GRCh37:
Chr1:201028369-201028370
GRCh38:
Chr1:201059241-201059242
CACNA1ST1158fsHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Pathogenic
(Jun 30, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr1:201028428
GRCh38:
Chr1:201059300
CACNA1SMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1Likely pathogenic
(Oct 16, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr1:201029865
GRCh38:
Chr1:201060737
CACNA1SW1112*not providedLikely pathogenic
(May 1, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr1:201029944
GRCh38:
Chr1:201060816
CACNA1SR1086Snot providedLikely pathogenic
(Sep 1, 2020)
criteria provided, single submitter
39.
GRCh37:
Chr1:201031099-201031100
GRCh38:
Chr1:201061971-201061972
CACNA1ST1009fsMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1Pathogenic
(Jul 1, 2019)
criteria provided, single submitter
40.
GRCh37:
Chr1:201031155
GRCh38:
Chr1:201062027
CACNA1SW990*Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Pathogenic
(Sep 1, 2021)
criteria provided, single submitter
41.
GRCh37:
Chr1:201031621
GRCh38:
Chr1:201062493
CACNA1SD959fsnot providedLikely pathogenic
(Jul 1, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr1:201031644
GRCh38:
Chr1:201062516
CACNA1SMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1Likely pathogenic
(Dec 16, 2020)
criteria provided, single submitter
43.
GRCh37:
Chr1:201034965
GRCh38:
Chr1:201065837
CACNA1SMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1Likely pathogenic
(Apr 20, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr1:201035007
GRCh38:
Chr1:201065879
CACNA1SL938fsMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1,
Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
Pathogenic/Likely pathogenic
(Aug 10, 2021)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr1:201035395
GRCh38:
Chr1:201066267
CACNA1SR903*not provided, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Pathogenic/Likely pathogenic
(Jan 23, 2023)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr1:201035402
GRCh38:
Chr1:201066274
CACNA1SR900SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Pathogenic
(Aug 16, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr1:201035402
GRCh38:
Chr1:201066274
CACNA1SR900SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Likely pathogenic
(Sep 1, 2021)
criteria provided, single submitter
48.
GRCh37:
Chr1:201035411
GRCh38:
Chr1:201066283
CACNA1SR897Snot providedPathogenic
(Feb 1, 2021)
criteria provided, single submitter
49.
GRCh37:
Chr1:201035412
GRCh38:
Chr1:201066284
CACNA1SR897KHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Pathogenic
(Jan 19, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr1:201036045
GRCh38:
Chr1:201066917
CACNA1SV876EHypokalemic periodic paralysis, type 1Likely pathogenic
(Oct 1, 2021)
criteria provided, single submitter
51.
GRCh37:
Chr1:201039430-201039436
GRCh38:
Chr1:201070302-201070308
CACNA1SE775fsMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1Pathogenic
(Nov 13, 2021)
criteria provided, single submitter
52.
GRCh37:
Chr1:201039467
GRCh38:
Chr1:201070339
CACNA1SQ765*Hypokalemic periodic paralysis, type 1Likely pathogenic
(Jul 26, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr1:201039491
GRCh38:
Chr1:201070363
CACNA1SR757*Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Pathogenic/Likely pathogenic
(Feb 13, 2022)
criteria provided, multiple submitters, no conflicts
54.
GRCh37:
Chr1:201041886
GRCh38:
Chr1:201072758
CACNA1SP742Snot providedPathogenic
(Apr 15, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr1:201041954
GRCh38:
Chr1:201072826
CACNA1SMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1Likely pathogenic
(Mar 18, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr1:201043633
GRCh38:
Chr1:201074505
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Likely pathogenic
(Jul 14, 2021)
criteria provided, single submitter
57.
GRCh37:
Chr1:201044724
GRCh38:
Chr1:201075596
CACNA1SW616*Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Pathogenic/Likely pathogenic
(Feb 23, 2022)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr1:201046079
GRCh38:
Chr1:201076951
CACNA1SN599fsMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1Pathogenic
(Apr 8, 2018)
criteria provided, single submitter
59.
GRCh37:
Chr1:201046141
GRCh38:
Chr1:201077013
CACNA1SM578IHypokalemic periodic paralysis, type 1Likely pathogenic
(May 28, 2019)
criteria provided, single submitter
60.
GRCh37:
Chr1:201047043
GRCh38:
Chr1:201077915
CACNA1SR528LMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1,
Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, not provided
Likely pathogenic
(Oct 16, 2022)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr1:201047043
GRCh38:
Chr1:201077915
CACNA1SR528Hnot provided, Hypokalemic periodic paralysis, type 1, Hypokalemic periodic paralysis, type 1,
Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1,
Malignant hyperthermia, susceptibility to, 5
Pathogenic
(Oct 21, 2022)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr1:201047044
GRCh38:
Chr1:201077916
CACNA1SR528CMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, not provided
Likely pathogenic
(Feb 9, 2021)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr1:201047044
GRCh38:
Chr1:201077916
CACNA1SR528GHypokalemic periodic paralysis, type 1Pathogenic
(Apr 12, 2022)
no assertion criteria provided
64.
GRCh37:
Chr1:201047123
GRCh38:
Chr1:201077995
CACNA1SC501*Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Pathogenic
(Mar 21, 2018)
criteria provided, single submitter
65.
GRCh37:
Chr1:201047212-201047225
GRCh38:
Chr1:201078084-201078097
CACNA1SN468fsHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1,
Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1
Pathogenic/Likely pathogenic
(Feb 2, 2022)
criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr1:201052317
GRCh38:
Chr1:201083189
CACNA1SQ456*Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Pathogenic
(Apr 18, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr1:201052409
GRCh38:
Chr1:201083281
CACNA1SC425fsHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Pathogenic
(Mar 3, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr1:201052414
GRCh38:
Chr1:201083286
CACNA1SW423*not providedLikely pathogenic
(Aug 17, 2018)
criteria provided, single submitter
69.
GRCh37:
Chr1:201052430-201052431
GRCh38:
Chr1:201083302-201083303
CACNA1SN418fsMalignant hyperthermia, susceptibility to, 5Pathogenic
(Sep 27, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr1:201052449
GRCh38:
Chr1:201083321
CACNA1SR412*Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1,
Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1
Pathogenic/Likely pathogenic
(May 25, 2022)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr1:201052451
GRCh38:
Chr1:201083323
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
Likely pathogenic
(Aug 9, 2022)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr1:201054627
GRCh38:
Chr1:201085499
CACNA1SL363fsHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Pathogenic
(Jul 26, 2021)
criteria provided, single submitter
73.
GRCh37:
Chr1:201058386
GRCh38:
Chr1:201089258
CACNA1SW300*Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, not provided
Pathogenic/Likely pathogenic
(Sep 18, 2022)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr1:201058389
GRCh38:
Chr1:201089261
CACNA1SY299*Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1Pathogenic
(Aug 1, 2018)
criteria provided, single submitter
75.
GRCh37:
Chr1:201058492
GRCh38:
Chr1:201089364
CACNA1SW265*Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Pathogenic
(May 27, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr1:201058554
GRCh38:
Chr1:201089426
CACNA1SC245fsHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Pathogenic
(Jun 4, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr1:201058592
GRCh38:
Chr1:201089464
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Likely pathogenic
(Jul 13, 2021)
criteria provided, single submitter
78.
GRCh37:
Chr1:201060898
GRCh38:
Chr1:201091770
CACNA1SI189fsHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Pathogenic
(Jul 11, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr1:201061139
GRCh38:
Chr1:201092011
CACNA1SR168*Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, not provided
Pathogenic/Likely pathogenic
(Sep 20, 2022)
criteria provided, multiple submitters, no conflicts
80.
GRCh37:
Chr1:201061205
GRCh38:
Chr1:201092077
CACNA1SQ146fsMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1Pathogenic
(Mar 22, 2018)
criteria provided, single submitter
81.
GRCh37:
Chr1:201063084
GRCh38:
Chr1:201093956
CACNA1SY108*Abnormality of the musculatureLikely pathogenic
(Jul 10, 2021)
criteria provided, single submitter
82.
GRCh37:
Chr1:201079290
GRCh38:
Chr1:201110162
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Likely pathogenic
(Mar 14, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr1:201079368
GRCh38:
Chr1:201110240
CACNA1SI61fsHypokalemic periodic paralysis, type 1Likely pathogenic
(Nov 16, 2021)
criteria provided, single submitter
84.
GRCh37:
Chr1:201081383
GRCh38:
Chr1:201112255
CACNA1SR29fsMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1Pathogenic
(Jun 8, 2021)
criteria provided, single submitter
85.
GRCh37:
Chr1:201081390
GRCh38:
Chr1:201112262
CACNA1SR26fsHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Pathogenic
(Nov 15, 2020)
criteria provided, single submitter
86.
GRCh37:
Chr1:201081449
GRCh38:
Chr1:201112321
CACNA1SQ7*Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Pathogenic
(Jan 30, 2020)
criteria provided, single submitter
87.
GRCh37:
Chr1:201012389-201013604
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5Pathogenic
(Jul 19, 2022)
criteria provided, single submitter
88.
CACNA1SMyopathy, congenital, due to dihydropyridine receptor defectPathogenic
(Mar 10, 2023)
no assertion criteria provided
89.
CACNA1SMyopathy, congenital, due to dihydropyridine receptor defectPathogenic
(Mar 10, 2023)
no assertion criteria provided
90.
CACNA1SMyopathy, congenital, due to dihydropyridine receptor defectPathogenic
(Mar 10, 2023)
no assertion criteria provided
91.
CACNA1SMyopathy, congenital, due to dihydropyridine receptor defectPathogenic
(Mar 10, 2023)
no assertion criteria provided
92.
CACNA1SMyopathy, congenital, due to dihydropyridine receptor defectPathogenic
(Mar 10, 2023)
no assertion criteria provided
93.
CACNA1SMyopathy, congenital, due to dihydropyridine receptor defectPathogenic
(Mar 10, 2023)
no assertion criteria provided
94.
CACNA1SMyopathy, congenital, due to dihydropyridine receptor defectPathogenic
(Mar 10, 2023)
no assertion criteria provided
95.
CACNA1SMyopathy, congenital, due to dihydropyridine receptor defectPathogenic
(Mar 10, 2023)
no assertion criteria provided
96.
CACNA1SMyopathy, congenital, due to dihydropyridine receptor defectPathogenic
(Mar 10, 2023)
no assertion criteria provided
97.
CACNA1SMyopathy, congenital, due to dihydropyridine receptor defectPathogenic
(Mar 10, 2023)
no assertion criteria provided
Format
Items per page
Sort by
Choose Destination